| Literature DB >> 35387261 |
Widad Ben Bakrim1,2, Agustina Dwi Retno Nurcahyanti3, Malak Dmirieh4, Ismail Mahdi1, Abdelbaset M Elgamal5, Mohamed A El Raey6, Michael Wink4, Mansour Sobeh1.
Abstract
We previously annotated the phytochemical constituents of a root extract from Ximenia americana var. caffra and highlighted its hepatoprotective and hypoglycemic properties. We here extended our study on the leaf extract and identified its phytoconstituents using HPLC-PDA-ESI-MS/MS. In addition, we explored its antioxidant, antibacterial, and antiaging activities in vitro and in an animal model, Caenorhabditis elegans. Results from HPLC-PDA-ESI-MS/MS confirmed that the leaves contain 23 secondary metabolites consisting of condensed tannins, flavonol glycosides, flavone glycosides, and flavonol diglycosides. The leaf extract demonstrated significant antioxidant activity in vitro with IC50 value of 5 μg/mL in the DPPH assay and 18.32 μg/mL in the FRAP assay. It also inhibited four enzymes (collagenase, elastase, hyaluronidase, and tyrosinase) crucially involved in skin remodeling and aging processes with comparable activities to reference drugs along with four pure secondary metabolites identified from the extract. In accordance with the in vitro result, in vivo tests using two transgenic strains of C. elegans demonstrated its ability to reverse oxidative stress. Evidence included an increased survival rate in nematodes treated with the prooxidant juglone to 68.9% compared to the 24.8% in untreated worms and a reduced accumulation of intracellular reactive oxygen species (ROS) in a dose-dependent manner to 77.8%. The leaf extract also reduced levels of the expression of HSP 16.2 in a dose-dependent manner to 86.4%. Nuclear localization of the transcription factor DAF-16 was up to 10 times higher in worms treated with the leaf extract than in the untreated worms. The extract also inhibited the biofilm formation of Pseudomonas aeruginosa (a pathogen in skin infections) and reduced the swimming and swarming mobilities in a dose-dependent fashion. In conclusion, leaves of X. americana are a promising candidate for preventing oxidative stress-induced conditions, including skin aging.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35387261 PMCID: PMC8979739 DOI: 10.1155/2022/3486257
Source DB: PubMed Journal: Oxid Med Cell Longev ISSN: 1942-0994 Impact factor: 6.543
Annotated secondary metabolites by HPLC-MS/MS analyses of the methanol extract of leaves from X. americana var. caffra.
| No. | Proposed compounds |
| [M-H]− ( | MS/MS fragments |
|---|---|---|---|---|
| 1 | Quinic acid | 1.41 | 191 | |
| 2 | Coumaroyl- | 3.12 | 477 | 169, 313 |
| 3 | Coumaroyl- | 3.38 | 477 | 169, 313 |
| 4 | (epi)-Catechin-(epi)-catechin-(epi)-catechin | 3.8 | 865 | 289, 577, 695 |
| 5 | (epi)-Catechin carboxylic ester | 4.38 | 333 | 245, 289, 315 |
| 6 | (epi)-Catechin-(epi)-catechin | 8.12 | 577 | 289, 407, 559 |
| 7 | Procyanidin B1 | 9.18 | 577 | 289, 407, 559 |
| 8 | Epicatechin | 10.09 | 289 | 179, 205, 245 |
| 9 | (epi)-Catechin-(epi)-catechin-(epi)-catechin | 10.63 | 865 | 287, 577, 695 |
| 10 | Catechin | 14.42 | 289 | 179, 205, 245 |
| 11 | Pyrogallol- | 14.86 | 453 | 169, 313 |
| 12 | Procyanidin dimer monogallate | 15.61 | 729 | 289, 425, 577 |
| 13 | (epi)-Catechin-(epi)-catechin | 17.96 | 577 | 289, 407, 559 |
| 14 | Quercetin galloyl-hexoside | 20.46 | 615 | 179, 301, 463 |
| 15 | Rutin | 21.06 | 609 | 179, 301, 463 |
| 16 | Isoquercetin | 22.05 | 463 | 151, 179, 301 |
| 17 | Avicularin | 24.03 | 433 | 151, 179, 301 |
| 18 | Kaempferol 3- | 25.46 | 447 | 285 |
| 19 | Kaempferol 3-neohesperidoside | 26.13 | 593 | 285 |
| 20 | Quercetin pentoside | 26.5 | 433 | 151, 179, 301 |
| 21 | Quercetin rhamnoside | 27.47 | 447 | 151, 179, 301 |
| 22 | Kaempferol 3- | 28.77 | 417 | 151, 179, 285 |
| 23 | Kaempferol pentoside | 31.46 | 417 | 151, 179, 285 |
Figure 1(a) LC-MS profile of X. americana var. caffra leaves. (b) Molecular network cluster of flavonoids. (c) MS/MS of catechin carboxylic acid (compound 5). Numbers of peaks refer to numbers in Table 1.
Antioxidant activities of the leaf methanol extract of X. a. caffra.
| Sample | DPPH (EC50, | FRAP (mM FeSO4/mg extract) |
|---|---|---|
| Leaf extract | 5 ± 0.15 | 18.32 ± 0.32 |
| Ascorbic acid (reference) | 2.92 ± 0.29 | |
| Quercetin (reference) | 24.04 ± 1.23 |
Enzymatic activities of the leaf methanol extract of X. a. caffra.
| Enzyme | Elastase | Hyaluronidase | Tyrosinase | Collagenase |
|---|---|---|---|---|
| IC50 ( | ||||
| Extract | 24.05 ± 2.53 | 13.66 ± 1.18 | 32.06 ± 1.18 | 39.55 ± 5.5 |
| Kojic acid | 21.60 ± 0.9 | 14.46 ± 0.6 | 9.00 ± 0.9 | — |
| Quinic acid | 143.75 ± 26.5 | 146.77 ± 11.3 | 61.91 ± 5.2 | 52.78 ± 1.8 |
| Rutin | 121.49 ± 22.8 | 57.39 ± 8.91 | 44.15 ± 5.25 | 63.46 ± 3.4 |
| Catechin | 15.00 ± 5.9 | 22.99 ± 0.2 | 22.54 ± 4.61 | 29.33 ± 2.4 |
| Epicatechin | 42.17 ± 5.7 | 53.39 ± 10.7 | 62.55 ± 2.3 | 65.96 ± 7.8 |
Figure 2Treatments of C. elegans with the leaf extract from X. americana: (a) survival rate after challenge with juglone; (b) intracellular ROS concentrations; (c) HSP-16.2:GFP expression; (d) DAF-16 subcellular translocation. Results were expressed as mean (n = 3). Significant differences relate to the control group at ∗∗p < 0.01 and ∗∗∗p < 0.001 by one-way ANOVA and Tukey's post hoc test.
Figure 3(a) Effect of the leaf extract from X. americana on the biofilm production by P. aeruginosa. Biofilm staining with 1% crystal violet visualized under microscopic visualization. (b) Inhibition of biofilm production using the leaf extract from X. americana at the doses of 3.13 mg/mL (1/8 MIC) and 6.25 mg/mL (1/4 MIC). n = 4. ∗Significantly different at p < 0.05 from the control.
Figure 4Effect of the leaf extract from X. americana on the swimming (a) and swarming mobility (b) of P. aeruginosa using the doses of 3.13 mg/mL (1/8 MIC) and 6.25 mg/mL (1/4 MIC). n = 4. a,bSignificantly different at p < 0.05 from the control and 3.13 mg/mL (1/8 MIC).